Language selection

Government of Canada / Gouvernement du Canada

Search

We have archived this page and will not be updating it.

You can use it for research or reference. For the latest data, please see the current report .

COVID-19 vaccination in Canada

Doses distributed Doses administered Vaccination coverage Understand the data

Older versions of this report are available on the archived reports page .

Doses administered

This page provides information on the number of COVID-19 vaccine doses that have been administered in Canada by jurisdiction, dose number and vaccine product. The number of vaccine doses administered is not the same as the number of people vaccinated.

We update information on the number of COVID-19 doses administered across Canada at different times:

On this page

Key updates as of {MMM DD, YYYY}

{Number of doses delivered}

total doses administered
since December 14, 2020

We update this number every weekday. Most provinces and territories do not update their numbers every day. Information on the number of doses administered comes from provincial or territorial websites and reports submitted by provincial and territorial partners (see data sources ).

About COVID-19 vaccination and approved vaccines

About COVID-19 vaccination and approved vaccines

Vaccination programs

  • COVID-19 vaccination began in Canada on December 14, 2020.
  • You’re currently eligible for COVID-19 vaccination if you’re 6 months of age or older and you don’t have contraindications to the vaccine.
  • The National Advisory Committee on Immunization (NACI) issues statements with recommendations on the use of COVID-19 vaccines . Briefly, NACI recommends:
    • a complete primary vaccine series to provide protection against COVID-19
    • booster doses after completing the primary series to restore or improve protection against COVID-19. Please refer to the COVID-19 vaccine chapter of the Canadian Immunization Guide for more details on:
      • booster eligibility
      • timing of a booster dose
      • recommended products
  • On March 3, 2023, NACI released their most recent statement . Starting in the spring of 2023, NACI recommends that:
    • An additional booster dose may be offered, 6 or more months after the last COVID-19 vaccine dose or infection, to individuals who are at risk of severe illness from COVID-19, including:
      • adults 80 years of age and older
      • adults 65 to 79 years of age, particularly if they do not have a known history of SARS-CoV-2infection
      • adult residents of long-term care homes and other congregate living settings for seniors, or those with complex medical needs
      • adults 18 years of age and older who are moderately to severely immunocompromised due to an underlying condition or treatment
    • The booster dose should preferably be a bivalent Omicron-containing mRNA vaccine.
    • Individuals who have not yet received previously recommended doses, including a primary series and fall 2022 booster, should receive them now, consistent with the Guidance on COVID-19 vaccine booster doses: Initial considerations for 2023

Approved vaccines

Vaccines authorized for use for primary vaccine series in Canada currently include:

3-dose vaccine

2-dose vaccines

1-dose vaccine

Vaccines currently authorized for use as booster doses in Canada include:

  • Pfizer-BioNTech Comirnaty
    • Pfizer-BioNTech Comirnaty for ages 5 to 11 years and 16 and older
    • Pfizer-BioNTech Comirnaty Bivalent:
      • Original and Omicron BA.4/BA.5 for ages 5 and older, and
      • Original and Omicron BA.1 for ages 12 and older
  • Moderna Spikevax
    • Moderna Spikevax for ages 18 and older
    • Moderna Spikevax Bivalent:
      • Original and Omicron BA.4/BA.5 for ages 18 and older, and
      • Original and Omicron BA.1 for ages 6 and older
  • Novavax Nuvaxovid for ages 18 and older

Local information

For local information on doses administered, please see your province’s or territory’s COVID-19 vaccination website .

Doses administered: Updates from provincial and territorial websites Access and download the national COVID-19 vaccine administration data in .csv format

Altogether, {Total doses administered} vaccine doses have been administered as of {MMM DD, YYYY} .

Figure 1. Cumulative number of COVID-19 vaccine administered in Canada by jurisdiction, as of DD MMM YYYY HH PM

Hover over or select a portion of the map to see the cumulative number of COVID-19 vaccine doses administered in Canada and each jurisdiction over time.

The cumulative number of COVID-19 vaccine doses {administered/distributed} in Canada was {1 000 / 0.1%} as of MMM DD, YYYY .
Access and download the national COVID-19 vaccine administration data in .csv format

Note: This information is based on the most current data available at the time of reporting. Green bars indicate the reported cumulative number of doses administered as of that date while grey bars are used for days where no data was reported. Due to differences in when provincial and territorial partners update their data, comparisons over time and between provinces and territories should be interpreted with caution (see data sources ). Information is subject to change and may differ from provincial and territorial reports depending on when data is updated (see limitations ).

Figure 1: Text description

Cumulative number of COVID-19 vaccine doses administered in Canada by jurisdiction as of MMM DD, YYYY

Doses administered: Reports from provinces and territories Access and download the national COVID-19 vaccine administration data by dose number and report week in .csv format

Information on doses administered by dose number and vaccine product is provided by provinces and territories every 4 weeks.

Figure 2. Number of COVID-19 vaccine doses administered in every 4 weeks by dose number, as of MMM DD, YYYY

Hover over or select a bar to see the number of doses administered by dose number and report week.

Figure 2. Number of COVID-19 vaccine doses administered in Canada every 4 weeks by dose number and jurisdiction, {MMM DD, YYYY}

Figure 2: Text description

Table 1. Cumulative number of COVID-19 vaccine doses administered in by vaccine product and dose number, as of MMM DD, YYYY

Vaccine product Total doses Dose 1 Dose 2 Dose 3 Dose 4 Dose 5+

Figure 3. Vaccine product breakdown of COVID-19 vaccine doses administered in by dose number, as of MMM DD, YYYY Access and download the national COVID-19 vaccine administration data by dose number and report week in .csv format

Hover over or select a bar to see the cumulative percentage of doses administered by dose number and vaccine product. Click on a legend element to add or remove the corresponding bars from the graph.

Figure 3. Vaccine product breakdown of COVID-19 vaccine doses administered in Canada by dose number, as of MMM DD, YYYY

Figure 3: Text description
Week ending Jurisdiction Vaccine product Total doses Dose 1 Dose 2 Dose 3 Dose 4 Dose 5+

Acknowledgements

This report would not be possible without the collaboration of provincial and territorial public health partners as well as members of the Pan-Canadian Public Health Network’s Canadian Immunization Registries and Coverage Network (CIRC). We would like to thank everyone taking part in the COVID-19 vaccination rollout in Canada.

Suggested citation

Public Health Agency of Canada. Canadian report on COVID-19 vaccine doses administered. Ottawa: Public Health Agency of Canada; MMM DD, YYYY . https://health-infobase.canada.ca/covid-19/vaccine-administration/

Related links

For health professionals

Date modified: